Home/Get Matched/NCT07284329
Recruiting
View on ClinicalTrials.gov

Testing Intervention (Video) Arm for consent process

Official title: Examining the Efficacy of a Digital Media Intervention to Increase Recruitment Rates

Examining the Efficacy of a Parent-targeted Co-designed Digital Media Intervention to Increase Recruitment Rates Across a Multi-site Randomized Clinical Trial in Canadian NICU's

Condition: Consent ProcessSponsor: IWK Health CentreTarget enrollment: 787
  • 2 groups
  • Sites in Edmonton, Vancouver and 12 more cities
  • Recruiting
Royal Alexandra Hospital, Edmonton, AlbertaBC Women's Hospital and Health Centre, Vancouver, British ColumbiaDr. Everett Chalmers, Fredericton, New BrunswickMoncton Hospital, Moncton, New BrunswickSaint John Regional Hospital, Saint John, New BrunswickIWK Health, Halifax, Nova ScotiaKingston Health Sciences Centre, Kingston, OntarioLondon Health Sciences Centre, London, OntarioThe Ottawa Hospital/CHEO, Ottawa, OntarioMount Sinai, Toronto, OntarioWindsor Regional Hospital, Windsor, OntarioCentre hospitalier de l'Université Laval, Laval, QuebecMontreal Children's Hospital, Montreal, QuebecCentre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec

Interventions

  • Behavioural therapy

    Intervention (Video) Arm

    A 3.5-4-minute co-designed digital media video created to supplement the standard consent process for the WHEAT International Trial.

Canadian Sites (15)

15 of 15 recruiting

  • Royal Alexandra Hospital

    Edmonton, Alberta

    Recruiting
  • BC Women's Hospital and Health Centre

    Vancouver, British Columbia

    Recruiting
  • Dr. Everett Chalmers

    Fredericton, New Brunswick

    Recruiting

Eligibility Criteria

See who this study is looking for7 criteria

The trial’s own eligibility text, word for word from the registry. Only the trial site can say who takes part.

Inclusion

  • +(applied to infants/participants in WHEAT Trial):
  • +Infant meets eligibility criteriaEligibility criteriaThe full list of requirements for taking part in a study.Read more → for the WHEAT International Trial
  • +Infant is \<30 weeks gestational age at birth
  • +Infant is admitted to one of the participating Canadian NICU sites
  • +Parent(s)/primary caregiver(s) are approached for consentInformed consentThe process of being told what taking part involves, then choosing freely.Read more → to participate in the WHEAT Trial during a time period when the SWAT is active at their siteTrial siteA hospital or clinic where a study is actually run.Read more →

Exclusion

  • Infant or family ineligible for participation in the WHEAT International Trial
  • Parent(s)/primary caregiver(s) not approached for WHEAT Trial participation (e.g., missed recruitment window, language barriers not addressed by materials, medical instability of infant or family)
5 concepts to explore on this page · up to 1,300 pointsTap any term to learn what it means.

In plain language

Assembled directly from this trial’s registry record. Every sentence traces to a field below — nothing here is generated or interpreted.

Learning 
What this study is

This study does not fall into the standard research categories.

This study is not organised into the usual phase numbers — that is common for device, behavioural, and diagnostic research.

From the trial registry

Built from these fields:

  • designModule.designInfo.primaryPurpose
  • designModule.phases
Who receives what

There are 2 groups in this study.

Group A receives no study treatment and is followed for comparison.

Registry label: A: Control (No-Video) Arm

Group B receives Intervention (Video) ArmArmOne of the groups in a study, each receiving something different.Read more →.

Registry label: B: Intervention (Video) Arm

From the trial registry

Built from these fields:

  • armsInterventionsModule.armGroups[].label
  • armsInterventionsModule.armGroups[].type
  • armsInterventionsModule.armGroups[].interventionNames
How the study is run

Which group you would be placed in is decided by chance, like a coin flip — not by you and not by your doctor.

This study is open-labelOpen-labelEveryone knows which treatment is being given — nothing is hidden.Read more →: everyone knows which treatment is being given, including you and the study team.

From the trial registry

Built from these fields:

  • designModule.designInfo.allocation
  • designModule.designInfo.maskingInfo.masking
Is there a placebo?

This study does not list a placeboPlaceboA dummy treatment with no active medicine, used for comparison.Read more → group.

One group receives no study treatment at all, and is followed for comparison.

From the trial registry

Built from these fields:

  • armsInterventionsModule.armGroups[].type
  • armsInterventionsModule.armGroups[].interventionNames
Who the study is looking for

The study lists a maximum age of 30 weeks.

The study is open to people of any sex.

The study does not accept healthy volunteersHealthy volunteerSomeone without the condition being studied who takes part anyway.Read more →.

These are the criteria the study lists. Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can decide whether someone can take part.

From the trial registry

Built from these fields:

  • eligibilityModule.maximumAge
  • eligibilityModule.sex
  • eligibilityModule.healthyVolunteers
How big and how long

The study aims to enrol about 787 people.

The study is currently expected to finish around April 2026.

The main measurement is taken over: BaselineBaselineYour starting measurements, taken before treatment begins.Read more → (When the family is approached for the Study Participation - Within first two weeks of life)).

From the trial registry

Built from these fields:

  • designModule.enrollmentInfo.count
  • statusModule.completionDateStruct.date
  • outcomesModule.primaryOutcomes[].timeFrame
What the study measures

Opt-in Rate for the WHEAT International Trial — measured over BaselineBaselineYour starting measurements, taken before treatment begins.Read more → (When the family is approached for the Study Participation - Within first two weeks of life)).

From the trial registry

Built from these fields:

  • outcomesModule.primaryOutcomes[].measure
  • outcomesModule.primaryOutcomes[].timeFrame

Source: NCT07284329 on ClinicalTrials.gov. The full registry text is further down this page — this summary never replaces it.

Not medical advice. What do these terms mean?

What is being tested — in plain terms

About Intervention (Video) ArmBehavioural

A 3.5-4-minute co-designed digital media video created to supplement the standard consent process for the WHEAT International Trial.

From the trial registry — its own words, unedited.

What a behavioural is here: A programme, therapy, education, or lifestyle approach being studied.

Read the full explanation → · in clinical review

Common questions

Answered from this trial’s registry record. Where the record doesn’t say, these answers say so rather than filling the gap.

Am I eligible for this trial?

Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can decide whether someone can take part. Concord cannot make that determination, and neither can any tool that has not examined you.

The full inclusionInclusion criteriaThe things you must have or be for a study to consider you.Read more → and exclusion criteriaExclusion criteriaThe things that would prevent someone from taking part.Read more → are published on this page, exactly as the study team wrote them.

The useful next step is to bring this trial to your doctor. Answering a few questions first gives them something concrete to review.

From the trial registry
  • eligibilityModule.eligibilityCriteria
Is there a placebo?

This study does not list a placeboPlaceboA dummy treatment with no active medicine, used for comparison.Read more → group.

One group receives no study treatment and is followed for comparison.

From the trial registry
  • armsInterventionsModule.armGroups[].type
Would I know which treatment I am getting?

This study is open-labelOpen-labelEveryone knows which treatment is being given — nothing is hidden.Read more →: everyone knows which treatment is being given, including you and the study team.

Which group you would be placed in is decided by chance, like a coin flip — not by you and not by your doctor.

From the trial registry
  • designModule.designInfo.maskingInfo.masking
  • designModule.designInfo.allocation
Who can join?

It is open to people of any sex.

It does not accept healthy volunteersHealthy volunteerSomeone without the condition being studied who takes part anyway.Read more →.

Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can confirm whether a particular person can take part.

From the trial registry
  • eligibilityModule.sex
  • eligibilityModule.healthyVolunteers
How long would this take?

The study's main measurement is taken over: BaselineBaselineYour starting measurements, taken before treatment begins.Read more → (When the family is approached for the Study Participation - Within first two weeks of life)).

The study as a whole is currently expected to finish around 2026-04-30.

How long any one person takes part can differ from the study length. The study team can tell you what the schedule looks like in practice.

From the trial registry
  • outcomesModule.primaryOutcomes[].timeFrame
  • statusModule.completionDateStruct.date
How many people are taking part?

The study aims to enrol about 787 people.

From the trial registry
  • designModule.enrollmentInfo.count
Where is this happening?

This study lists 15 locations, including: Edmonton, Alberta, Canada; Vancouver, British Columbia, Canada; Saint Johns, NFLD, Canada; Fredericton, New Brunswick, Canada; Moncton, New Brunswick, Canada; Saint John, New Brunswick, Canada, and 9 more.

Sites can open and close during a study, so confirm with the team before travelling.

From the trial registry
  • trial_locations

About This Trial

WHEAT-Boost is a Study Within A Trial (SWAT) that aims to improve how families are recruited into neonatal research studies by testing a new way of sharing information. The study is embedded within the larger WHEAT International Trial, a randomized clinical trial being conducted in Neonatal Intensive Care Units (NICUs) across Canada. The WHEAT International Trial investigates the best way to manage feeding around the time of blood transfusions in very premature infants (born before 30 weeks of pregnancy). Recruiting families for research in the NICU is challenging. Parents are often stressed, overwhelmed, and unfamiliar with how clinical trials work, which can make it hard for them to process complex medical information and decide whether to take part. Traditional consent methods, such as paper forms, may not be enough to ensure families feel informed and comfortable with participation. To address this, WHEAT-Boost will test whether adding a short, co-designed digital video helps improve recruitment rates. The video is 3.5 to 4 minutes long, available in English and French (with subtitles in other commonly spoken languages), and explains the importance of NICU research and details of the WHEAT International Trial in a simple and visual way. The video was co-developed with parents who have experience in the NICU to ensure the information is relevant and easy to understand. NICU sites participating in the WHEAT Trial will be randomly assigned, in a stepped-wedge design schedule, to either continue using their usual recruitment methods, or to add the digital video to their recruitment approach. Parents in both groups will be asked to complete a short, voluntary questionnaire about their experience with the consent process and their understanding of the trial. The main goal of WHEAT-Boost is to see if the video increases the number of families who agree to take part in the WHEAT Trial (known as the "opt-in rate"). The study will also look at whether the video reduces the number of families who later withdraw from the trial, and whether it improves parents' understanding of the study and their satisfaction with how information was shared. If successful, the video could be used in other NICUs or future studies to help make research more accessible and inclusive for families. This approach could lead to stronger participation in neonatal trials, better-informed decisions by parents, and faster progress in improving care for premature babies.

Think this trial might be right for you?

Complete a quick intake form and we will match you with this and other relevant trials based on your medical profile.

See if this trial could fit you

This page is for informational purposes only and does not constitute medical advice. Clinical trial eligibility can only be determined by the trial site after proper screening. Trial information is sourced from ClinicalTrials.gov and may not reflect the most current status. Always consult your healthcare provider before making decisions about clinical trial participation.